Syneos Health - SYNH Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings or view top-rated stocks.

10 equities research analysts have issued 1-year price targets for Syneos Health's stock. Their SYNH share price forecasts range from $28.00 to $81.00. On average, they anticipate the company's stock price to reach $54.00 in the next twelve months. This suggests a possible upside of 57.3% from the stock's current price.
View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts.

Syneos Health's stock was trading at $36.68 at the beginning of 2023. Since then, SYNH stock has decreased by 6.4% and is now trading at $34.33.
View the best growth stocks for 2023 here.

Syneos Health saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 3,430,000 shares, a drop of 46.6% from the February 28th total of 6,420,000 shares. Based on an average daily trading volume, of 1,630,000 shares, the days-to-cover ratio is currently 2.1 days. Currently, 3.4% of the company's stock are sold short.
View Syneos Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our SYNH earnings forecast.

Syneos Health, Inc. (NASDAQ:SYNH) issued its quarterly earnings results on Thursday, February, 16th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.07 by $0.08. The business earned $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Syneos Health had a net margin of 4.94% and a trailing twelve-month return on equity of 13.19%.

ETFs with the largest weight of Syneos Health (NASDAQ:SYNH) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), Invesco S&P MidCap 400 Pure Value ETF (RFV), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), First Trust Mid Cap Value AlphaDEX Fund (FNK), Syntax Stratified MidCap ETF (SMDY), Vanguard Small-Cap Growth ETF (VBK), Vanguard U.S. Value Factor (VFVA) and Humankind US Stock ETF (HKND).

Syneos Health updated its FY 2023 earnings guidance on Monday, February, 20th. The company provided earnings per share (EPS) guidance of $3.26-$3.53 for the period, compared to the consensus estimate of $3.89. The company issued revenue guidance of $4.97 billion-$5.17 billion, compared to the consensus revenue estimate of $5.13 billion.

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Syneos Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (4.03%), Mackenzie Financial Corp (2.25%), JPMorgan Chase & Co. (2.12%), AQR Capital Management LLC (2.10%), Alliancebernstein L.P. (2.05%) and Cooke & Bieler LP (1.83%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends.

Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SYNH stock can currently be purchased for approximately $34.33.

Syneos Health (NASDAQ:SYNH) has a market capitalization of $3.54 billion and generates $5.39 billion in revenue each year. The company earns $266.50 million in net income (profit) each year or $2.57 on an earnings per share basis.

The company employs 29,395 workers across the globe.

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.